Immunohistochemical expression of PRAME is a marker of poor prognosis in uveal melanoma: A clinico-pathologic and immunohistochemical study on a series of 85 cases
Giuseppe Broggi(University of Catania), Rosario Caltabiano(University of Catania), Silvia Varricchio(University of Naples Federico II), Francesco Merolla(University of Molise), Carla Loreto(University of Catania), Rosa Maria Di Crescenzo(University of Naples Federico II), Maria Failla(University of Catania), Magda Zanelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Andrea Palicelli(Azienda Sanitaria Unità Locale di Reggio Emilia), Gennaro Ilardi(University of Naples Federico II), Antonio Longo(University of Catania), Stefania Staibano(University of Naples Federico II), Andrea Russo(University of Catania), Claudia Lombardo(University of Catania)
Cited by 19
Related Papers
<i>BRAF/NRAS</i> Mutation Frequencies Among Primary Tumors and Metastases in Patients With Melanoma
|Journal of Clinical Oncology|2012|460
CircSMARCA5 Regulates VEGFA mRNA Splicing and Angiogenesis in Glioblastoma Multiforme Through the Binding of SRSF1
|Cancers|2019|230
Accuracy in melanoma detection: A 10-year multicenter survey
|Journal of the American Academy of Dermatology|2011|209
The Spectrum of Spitz Nevi
|Archives of Dermatology|2005|173
Surgical Treatment of Spasticity in Cerebral Palsy
|Pediatric Neurosurgery|1978|166